Matt Kelly is Perspectum’s Chief Innovation Officer, overseeing clinical studies and collaborations to support our technology and explore novel indications. Matt is also responsible for the data-driven evaluation of Perspectum’s technology and IP management. Matt brings 20 years of experience in academic and industrial research in the biomedical sciences to Perspectum. Since completing his B.Sc. in Neuroscience at Manchester University and PhD in Pharmacology at De Novo Pharmaceuticals, a University of Cambridge spin-out, Matt has worked at the University of Oxford and Siemens Healthcare developing state-of-the-art technology for medical imaging and oncology. Matt has had over 25 patents granted and published 23 peer-reviewed journal articles.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.